Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

Jun 23, 2013 8:30 AM - Jun 27, 2013 12:45 PM

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Protocol Trends and Strategies for Quality

Session Chair(s)

Linda Fossati Wood

Linda Fossati Wood

President

MedWrite, Inc., United States

Assessing the Impact of Regulatory and Scientific Pressures on Protocol Design

Learning Objective : Discuss the value of protocol review committees to improving protocol quality; Describe protocol design elements associated with specific objectives and endpoints; Recognize how a medical writer’s perspective can improve data collection and analysis tools; Identify key points to look for when reviewing case report forms and statistical analysis plans; Name suggestions for improvement of these documents.

Speaker(s)

Anne  Cropp, PharmD

Protocol Quality Tools: New Approaches to an Old Problem

Anne Cropp, PharmD

Early Access Care LLC, United States

Chief Scientific Officer

Kenneth  Getz, MBA

Assessing the Impact of Regulatory and Scientific Pressures on Protocol Design

Kenneth Getz, MBA

Center For the Study of Drug Development, United States

Tufts Center for the Study of Drug Development

Kim  Jochman, PhD

After the Protocol: How Medical Writer Engagement During the Lifespan of a Study Can Help Ensure Quality Results

Kim Jochman, PhD

Merck & Co., Inc., United States

Senior Director, Medical Writing

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.